Description
BREvipil Injection is a prescription medicine manufactured by Sun Pharmaceutical Industries Ltd. It contains Brivaracetam (10mg/ml), an antiepileptic drug that helps control seizure episodes quickly by modulating neurotransmitter activity in the brain.
The injectable form is used when oral administration is not feasible, such as in patients unable to swallow tablets, or in hospital settings for acute seizure management.
Uses
-
Rapid control of partial-onset seizures
-
Management of seizure episodes when oral medication cannot be taken
-
Can be used alone or as adjunct therapy with other antiepileptic drugs
Dosage
-
Administered as prescribed by a doctor or healthcare professional
-
Usually given via intravenous (IV) injection
-
Dosage may vary based on age, weight, and clinical condition
Side Effects
-
Drowsiness, dizziness, or fatigue
-
Nausea or vomiting
-
Irritability or mood changes
-
Rare: severe allergic reactions or injection site reactions
Precautions
-
Inform your doctor about any history of depression, suicidal thoughts, or liver/kidney issues
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Avoid abrupt discontinuation as it may trigger seizures
-
Monitor vital signs and neurological status during administration
Storage
-
Store in a cool, dry place, away from sunlight and moisture
-
Keep out of reach of children
-
Use sterile technique; do not use if solution is discolored or contains particles
Leave a Reply